Literature DB >> 19651619

GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells.

Dat Q Tran1, John Andersson, Rui Wang, Heather Ramsey, Derya Unutmaz, Ethan M Shevach.   

Abstract

TGF-beta family members are highly pleiotropic cytokines with diverse regulatory functions. TGF-beta is normally found in the latent form associated with latency-associated peptide (LAP). This latent complex can associate with latent TGFbeta-binding protein (LTBP) to produce a large latent form. Latent TGF-beta is also found on the surface of activated FOXP3(+) regulatory T cells (Tregs), but it is unclear how it is anchored to the cell membrane. We show that GARP or LRRC32, a leucine-rich repeat molecule of unknown function, is critical for tethering TGF-beta to the cell surface. We demonstrate that platelets and activated Tregs co-express latent TGF-beta and GARP on their membranes. The knockdown of GARP mRNA with siRNA prevented surface latent TGF-beta expression on activated Tregs and recombinant latent TGF-beta1 is able to bind directly with GARP. Confocal microscopy and immunoprecipitation strongly support their interactions. The role of TGF-beta on Tregs appears to have dual functions, both for Treg-mediated suppression and infectious tolerance mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651619      PMCID: PMC2726354          DOI: 10.1073/pnas.0901944106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.

Authors:  Lili Xu; Atsushi Kitani; Ivan Fuss; Warren Strober
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

2.  Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

Authors:  Dat Q Tran; Heather Ramsey; Ethan M Shevach
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

3.  Cutting Edge: Immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner.

Authors:  Roopali Gandhi; David E Anderson; Howard L Weiner
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

4.  Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.

Authors:  Chung-Ji Liu; Shu-Chun Lin; Yann-Jang Chen; Kuo-Ming Chang; Kuo-Wei Chang
Journal:  Mol Carcinog       Date:  2006-10       Impact factor: 4.784

5.  Role and regulation of the serum- and glucocorticoid-regulated kinase 1 in fertile and infertile human endometrium.

Authors:  Fakhera Feroze-Zaidi; Luca Fusi; Masashi Takano; Jenny Higham; Madhuri S Salker; Tomoko Goto; Seby Edassery; Karin Klingel; Krishna Murthy Boini; Monica Palmada; Rick Kamps; Patrick G Groothuis; Eric W-F Lam; Stephen K Smith; Florian Lang; Andrew M Sharkey; Jan J Brosens
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

6.  Gene amplifications associated with the development of hormone-resistant prostate cancer.

Authors:  Joanne Edwards; N Sarath Krishna; Caroline J Witton; John M S Bartlett
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

7.  Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins.

Authors:  Iain C Macaulay; Marloes R Tijssen; Daphne C Thijssen-Timmer; Arief Gusnanto; Michael Steward; Philippa Burns; Cordelia F Langford; Peter D Ellis; Frank Dudbridge; Jaap-Jan Zwaginga; Nicholas A Watkins; C Ellen van der Schoot; Willem H Ouwehand
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

8.  Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice.

Authors:  Zhiwei Yang; Zhenyu Mu; Branka Dabovic; Vladimir Jurukovski; Dawen Yu; Joanne Sung; Xiaozhong Xiong; John S Munger
Journal:  J Cell Biol       Date:  2007-03-12       Impact factor: 10.539

9.  Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression.

Authors:  Rui Wang; Qi Wan; Lina Kozhaya; Hodaka Fujii; Derya Unutmaz
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

10.  CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner.

Authors:  John Andersson; Dat Q Tran; Marko Pesu; Todd S Davidson; Heather Ramsey; John J O'Shea; Ethan M Shevach
Journal:  J Exp Med       Date:  2008-08-18       Impact factor: 14.307

View more
  218 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

2.  The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients.

Authors:  Xingnan Li; Elizabeth J Ampleford; Timothy D Howard; Wendy C Moore; Huashi Li; William W Busse; Mario Castro; Serpil C Erzurum; Anne M Fitzpatrick; Benjamin Gaston; Elliot Israel; Nizar N Jarjour; W Gerald Teague; Sally E Wenzel; Gregory A Hawkins; Eugene R Bleecker; Deborah A Meyers
Journal:  J Allergy Clin Immunol       Date:  2011-11-08       Impact factor: 10.793

3.  Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.

Authors:  Huahua Fan; Jie Yang; Jun Hao; Yana Ren; Liang Chen; Guiping Li; Rufeng Xie; Yiming Yang; Feng Gao; Mingyao Liu
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

4.  Perspectives on Regulatory T Cell Therapies.

Authors:  Michael Probst-Kepper; Andrea Kröger; Henk S P Garritsen; Jan Buer
Journal:  Transfus Med Hemother       Date:  2009-09-10       Impact factor: 3.747

5.  Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß.

Authors:  Takatoku Oida; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 6.  The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.

Authors:  Yunsheng Liang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

7.  Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells.

Authors:  Samik Basu; Britany Hubbard; Ethan M Shevach
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

8.  Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses.

Authors:  Yong Chan Kim; Ai-Hong Zhang; Yan Su; Sadiye Amcaoglu Rieder; Robert J Rossi; Ruth A Ettinger; Kathleen P Pratt; Ethan M Shevach; David W Scott
Journal:  Blood       Date:  2014-12-10       Impact factor: 22.113

9.  Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Authors:  Jason S Ellis; So-Hee Hong; Habib Zaghouani; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

Review 10.  TGF-β: guardian of T cell function.

Authors:  Soyoung A Oh; Ming O Li
Journal:  J Immunol       Date:  2013-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.